The 3rd Research Day for Patients’ Associations took place on 6 September, focusing on colorectal cancer patients. The day began…
Colorectal Cancer Group
Reported today during a Proffered Paper session at the ESMO Gastrointestinal Cancers Annual Congress (ESMO GI) 2024*, first health-related quality…
Results of the study FRESCO-2 show a statistically and clinically meaningful benefit with a favorable safety profile in patients with…
Published in The Lancet Oncology results of the multicenter phase II MOUNTAINEER study (1) show that tucatinib plus trastuzumab had…
The New England Journal of Medicine publishes today the results of the SUNLIGHT study, a Phase III clinical trial comparing…
Published ahead of print in Nature Medicine*, the final efficacy and safety results of the ROAR basket study led by…
